Coverage recommandation for our innovative IVD test METAglut™ by French National Authority for Health (HAS)
May 3, 2023
Translating the regulatory landscape of medical devices to create fit-for-purpose artificial intelligence (AI) cytometry solutions
February 23, 2024
June 20, 2023
[EVENTS] Company ; METAglut1™
We had the honor of attending the 15th Annual Meeting of the European Paediatric Neurology Society (EPNS), a key event dedicated to advancing the field of pediatric neurology in Europe.
This gathering, happening in Prague, brought together leading experts and practitioners in pediatric neurology to discuss the latest research and advancements in the field.
We had the opportunity to discuss with leading experts and practitioners in pediatric neurology about METAglut1™, our innovative IVD blood test, designed to aid the early diagnosis of GLUT1DS.
Glut1 Deficiency Syndrom (Glut1DS), also known as De Vivo Disease, is a rare neuro metabolic disorder that can significantly impact the lives of affected children.
We believe that our diagnostic tool represents a significant advancement in identifying the condition, which can have profound implications for affected individuals and their families.
This event provided an important platform to emphasize the critical need for increased awareness about rare, low-prevalence conditions like Glut1 Deficiency Syndrome (Glut1DS).
About the event organizer
The European Paediatric Neurology Society (EPNS) is a non profit making independent Society for physicians, trainees/residents, PhD students, health professionals, scientists and students with a research or clinical interest in Child Neurology.
A group of like-minded active professionals who are committed to improving standards of care of all children with neurological problems and to collaborating on training, continuing medical education and research.
The EPNS Board is dedicated to developing paediatric neurology, give training and education to younger colleagues at the highest level and to start new scientific and vibrant collaborations.
We would like to extend our heartfelt thanks and congratulations to the distinguished speakers of the 2023 Annual meeting: Alexis Arzimanoglou, Juan Dario Ortigoza-Escobar, Teresinha Evangelista, Maurizio Scarpa and Alain Verloes for their insightful presentations. Their expertise significantly enriched the discussions surrounding rare and complex diseases.
Sharing our latest news on METAglut1™ and raising awareness at the Annual Meeting of the European Paediatric Neurology Society (EPNS) has invigorated our commitment to advancing research and innovation in pediatric health. We are dedicated to collaborating with experts and stakeholders to improve patient outcomes and have the test as fast as possible covered and available.
